Reverse Transcription Recombinase Polymerase Amplification Assay for the Detection of Middle East Respiratory Syndrome Coronavirus
Open Access
- 1 January 2013
- journal article
- Published by Public Library of Science (PLoS) in PLoS Currents
Abstract
The emergence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in the eastern Mediterranean and imported cases to Europe has alerted public health authorities. Currently, detection of MERS-CoV in patient samples is done by real-time RT-PCR. Samples collected from suspected cases are sent to highly-equipped centralized laboratories for screening. A rapid point-of-care test is needed to allow more widespread mobile detection of the virus directly from patient material. In this study, we describe the development of a reverse transcription isothermal Recombinase Polymerase Amplification (RT-RPA) assay for the identification of MERS-CoV. A partial nucleocapsid gene RNA molecular standard of MERS-coronavirus was used to determine the assay sensitivity. The isothermal (42°C) MERS-CoV RT-RPA was as sensitive as real-time RT-PCR (10 RNA molecules), rapid (3-7 minutes) and mobile (using tubescanner weighing 1kg). The MERS-CoV RT-RPA showed cross-detection neither of any of the RNAs of several coronaviruses and respiratory viruses affecting humans nor of the human genome. The developed isothermal real-time RT-RPA is ideal for rapid mobile molecular MERS-CoV monitoring in acute patients and may also facilitate the search for the animal reservoir of MERS-CoVKeywords
This publication has 16 references indexed in Scilit:
- A Portable Reverse Transcription Recombinase Polymerase Amplification Assay for Rapid Detection of Foot-and-Mouth Disease VirusPLOS ONE, 2013
- Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infectionThe Lancet Infectious Diseases, 2013
- Development of a Panel of Recombinase Polymerase Amplification Assays for Detection of Biothreat AgentsJournal of Clinical Microbiology, 2013
- Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infectionsEurosurveillance, 2012
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi ArabiaNew England Journal of Medicine, 2012
- Recombinase polymerase amplification assay for rapid detection of Rift Valley fever virusJournal of Clinical Virology, 2012
- Recombinase Polymerase Amplification Assay for Rapid Detection of Francisella tularensisJournal of Clinical Microbiology, 2012
- Rapid detection of important human pathogenic PhlebovirusesJournal of Clinical Virology, 2008
- DNA Detection Using Recombination ProteinsPLoS Biology, 2006
- Health risks at the HajjThe Lancet, 2006